InvestSMART

Tetratherix Limited (ASX: TTX) - Announcements

Current share price for TTX : $6.650 0.1 (1.48%)+

ASX company news and announcements for Tetratherix Limited (TTX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Tetratherix Limited (TTX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Tetratherix Limited (TTX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Tetratherix Limited (TTX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$196 Quarterly Activities/Appendix 4C Cash Flow Report 22 Jul 2026 8:24AM $6.750 $6.650 fallen by 1.48%
$196 Notification regarding unquoted securities - TTX 1 Jul 2026 1:53PM $6.000 $6.650 risen by 10.83%
$196 Tutela Interim Study Results 23 Jun 2026 9:53AM $5.920 $6.650 risen by 12.33%
$196 Application for quotation of securities - TTX 23 Jun 2026 8:15AM $5.920 $6.650 risen by 12.33%
$196 SPP Results 22 Jun 2026 8:17AM $5.920 $6.650 risen by 12.33%
$196 Application for quotation of securities - TTX 19 Jun 2026 8:19AM $6.000 $6.650 risen by 10.83%
$196 Mandatory Escrow Release 9 Jun 2026 10:46AM $5.880 $6.650 risen by 13.10%
$196 Study Results Peptide-Polymer Patents 9 Jun 2026 8:33AM $5.900 $6.650 risen by 12.71%
$196 SPP Booklet 4 Jun 2026 9:16AM $6.300 $6.650 risen by 5.56%
$196 Placement Cleansing Notice 4 Jun 2026 9:10AM $6.300 $6.650 risen by 5.56%
$196 Application for quotation of securities - TTX 3 Jun 2026 8:20AM $6.790 $6.650 fallen by 2.06%
$196 Proposed issue of securities - TTX 28 May 2026 9:23AM $6.810 $6.650 fallen by 2.35%
$196 Successful Completion $15M Placement 28 May 2026 9:22AM $6.810 $6.650 fallen by 2.35%
$196 Trading Halt 26 May 2026 9:29AM $6.810 $6.650 fallen by 2.35%
$196 Quarterly Activities/Appendix 4C Cash Flow Report 23 Apr 2026 9:26AM $4.780 $6.650 risen by 39.12%
$196 Notification regarding unquoted securities - TTX 1 Apr 2026 8:20AM $4.120 $6.650 risen by 61.41%
$196 Tetratherix March Investor Presentation 17 Mar 2026 8:30AM $5.090 $6.650 risen by 30.65%
$196 Precision medicine franchise launch and new revenue 16 Mar 2026 8:17AM $4.160 $6.650 risen by 59.86%
$196 Tutelix Update 10 Mar 2026 9:21AM $3.810 $6.650 risen by 74.54%
$196 HY FY26 Letter 24 Feb 2026 11:08AM $3.860 $6.650 risen by 72.28%
$196 Half Yearly Report and Accounts 24 Feb 2026 10:27AM $3.860 $6.650 risen by 72.28%
$196 TetraDerm Cohort 1 Results 17 Feb 2026 8:15AM $3.620 $6.650 risen by 83.70%
$196 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jan 2026 8:21AM $3.830 $6.650 risen by 73.63%
$196 Initial Director's Interest Notice 21 Jan 2026 11:51AM $3.480 $6.650 risen by 91.09%
$196 Vecchione Appointment 21 Jan 2026 11:47AM $3.480 $6.650 risen by 91.09%

1 - 25 of 122 results

Page 1 of 5

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.